TGA Approval

OPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial (318057)

ARTG ID

318057

ARTG Name

OPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

April 9, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-01052-1

Ingredient Name

nivolumab

Empowering clinical research with data-driven insights and AI-powered tools.

OPDIVO nivolumab 240 mg in 24 mL (10 mg/mL) concentrate solution for IV infusion vial (318057) - TGA 批准文号 | MedPath